ArticleFrontiers in medicine2026
Analysis of heart rate variability in critical septic patients using a smartphone application: a prospective cohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Heart rate variability (HRV) reflects autonomic nervous system modulation and has been associated with mortality in sepsis. However, in the intensive care unit (ICU), HRV assessment with traditional equipment limits its use. This study aimed to investigate the association between HRV measured by a mobile application and mortality in septic patients. Methods: This is a prospective observational cohort study conducted in two ICUs in Curitiba, Brazil, between July 2024 and March 2026, including septic patients (≥18 years) within 24 h of sepsis diagnosis. HRV, assessed using the standard deviation of NN intervals (SDNN), was measured through a heart rate monitor strap for 5 min over 3 consecutive days; clinical and hemodynamic data were also collected. Pregnancy, patients in exclusive palliative care, skin lesions that could interfere with the cardiac sensor, and decompensated irregular heart rhythm signs during data collection were excluded. The primary outcome was 28-day mortality. Results: A total of 112 septic patients were included, with an overall 28-day mortality of 49%. Non-survivors had a significantly higher APACHE II (30 vs. 22, Conclusion: HRV assessed by a mobile application demonstrated a significant association with 28-day mortality in septic patients, with lower SDNN values at 72 h. This method might facilitate the wider implementation of HRV monitoring in resource-limited ICUs to stratify mortality in septic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.